OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 5
Data from combined, up to 2021-03-17.
| Vaccinated at 2021-03-17 (%) | Vaccinated at 2021-03-17 (n) | Population | Vaccinated at 2021-03-10 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 59.4% | 1,467,921 | 2,472,862 | 57.6% | 1.7% |
| Sex | Female | 59.3% | 747,551 | 1,261,582 | 57.6% | 1.6% |
| Male | 59.5% | 720,370 | 1,211,280 | 57.7% | 1.8% | |
| Ethnicity | White - British | 62.1% | 899,451 | 1,448,937 | 60.5% | 1.6% |
| White - Irish | 56.2% | 8,785 | 15,624 | 54.9% | 1.3% | |
| White - Any other White background | 43.6% | 34,503 | 79,226 | 42.0% | 1.5% | |
| Mixed - White and Black Caribbean | 41.2% | 1,309 | 3,178 | 38.8% | 2.4% | |
| Mixed - White and Black African | 41.4% | 1,064 | 2,569 | 39.5% | 1.9% | |
| Mixed - White and Asian | 52.9% | 1,351 | 2,555 | 51.2% | 1.6% | |
| Mixed - Any other mixed background | 46.5% | 2,303 | 4,949 | 44.7% | 1.8% | |
| Asian or Asian British - Indian | 53.3% | 26,831 | 50,323 | 52.1% | 1.2% | |
| Asian or Asian British - Pakistani | 46.3% | 11,578 | 25,004 | 43.8% | 2.5% | |
| Asian or Asian British - Bangladeshi | 53.8% | 3,332 | 6,195 | 51.1% | 2.7% | |
| Asian or Asian British - Any other Asian background | 48.9% | 10,990 | 22,463 | 47.5% | 1.4% | |
| Black or Black British - Caribbean | 38.4% | 5,747 | 14,959 | 36.0% | 2.4% | |
| Black or Black British - African | 39.0% | 5,950 | 15,267 | 36.5% | 2.5% | |
| Black or Black British - Any other Black background | 42.0% | 1,533 | 3,647 | 39.9% | 2.1% | |
| Other ethnic groups - Chinese | 47.8% | 4,501 | 9,408 | 46.2% | 1.6% | |
| Other ethnic groups - Any other ethnic group | 43.0% | 5,698 | 13,258 | 41.3% | 1.7% | |
| Patients with any other ethnicity code | 59.3% | 194,341 | 327,453 | 57.5% | 1.9% | |
| Ethnicity not stated | 58.3% | 8,799 | 15,085 | 56.4% | 1.9% | |
| Ethnicity not recorded | 58.1% | 239,757 | 412,664 | 56.2% | 1.9% | |
| Ethnicity (broad categories) | White | 61.1% | 942,753 | 1,543,801 | 59.5% | 1.6% |
| Mixed | 45.6% | 6,041 | 13,258 | 43.6% | 2.0% | |
| South Asian | 50.7% | 52,759 | 103,999 | 49.1% | 1.6% | |
| Black | 39.1% | 13,237 | 33,887 | 36.7% | 2.4% | |
| Other | 45.1% | 10,213 | 22,666 | 43.4% | 1.7% | |
| Unknown | 58.6% | 442,911 | 755,216 | 56.8% | 1.9% | |
| Index of Multiple Deprivation | 1 (most deprived) | 53.6% | 197,631 | 368,403 | 51.1% | 2.6% |
| 2 | 57.0% | 252,308 | 442,505 | 54.9% | 2.1% | |
| 3 | 59.6% | 312,641 | 524,734 | 57.9% | 1.7% | |
| 4 | 61.4% | 338,716 | 551,642 | 60.0% | 1.4% | |
| 5 (least deprived) | 62.8% | 354,144 | 563,983 | 61.6% | 1.2% | |
| Unknown | 57.8% | 12,460 | 21,560 | 55.9% | 1.9% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 59.9% | 542,556 | 905,709 | 58.2% | 1.7% |
| Patients with Immunosuppression | 60.6% | 22,834 | 37,674 | 59.1% | 1.5% | |
| Patients with CKD | 60.3% | 70,385 | 116,683 | 58.7% | 1.6% | |
| Patients who have Chronic Respiratory Disease | 60.0% | 57,939 | 96,572 | 58.2% | 1.8% | |
| Patients with Diabetes | 59.2% | 192,563 | 325,458 | 57.5% | 1.7% | |
| Patients with Chronic Liver disease | 59.0% | 43,400 | 73,591 | 57.2% | 1.7% | |
| Patients with CNS Disease (including Stroke/TIA) | 61.0% | 82,404 | 135,163 | 59.1% | 1.9% | |
| Patients with Chronic heart disease | 60.5% | 227,213 | 375,452 | 58.9% | 1.7% | |
| Patients with Asplenia or Dysfunction of the Spleen | 62.0% | 8,778 | 14,168 | 60.7% | 1.2% | |
| Patients with Wider Learning Disability | 59.8% | 3,472 | 5,810 | 55.2% | 4.6% | |
| Patients with Severe Mental Health | 54.9% | 13,034 | 23,758 | 52.0% | 2.9% | |
| Other Groups | Patients with Morbid Obesity | 59.7% | 46,620 | 78,113 | 57.7% | 2.0% |
| Patients who are pregnant | 61.1% | 154 | 252 | 58.3% | 2.8% |